344 related articles for article (PubMed ID: 35328487)
21. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).
Panagopoulos I; Micci F; Thorsen J; Haugom L; Tierens A; Ulvmoen A; Heim S
Cancer Genet; 2012 Dec; 205(12):669-72. PubMed ID: 23181981
[TBL] [Abstract][Full Text] [Related]
22. Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases.
Zhang J; Yang F; Qiu HY; Wu Q; Kong DQ; Zhou J; Han Y; Wu DP
Leuk Lymphoma; 2019 Jun; 60(6):1454-1461. PubMed ID: 30714847
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.
Gu R; Liu F; Zou D; Xu Y; Lu Y; Liu B; Liu W; Chen X; Liu K; Guo Y; Gong X; Lv R; Chen X; Zhou C; Zhong M; Wang H; Wei H; Mi Y; Qiu L; Lv L; Wang M; Wang Y; Zhu X; Wang J
J Hematol Oncol; 2020 Sep; 13(1):122. PubMed ID: 32894185
[TBL] [Abstract][Full Text] [Related]
24. New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia.
Lanza F; Maffini E; Saraceni F; Massari E; Rondoni M; Daghia G; Olivieri A; Cerchione C; Martinelli G
Minerva Med; 2020 Oct; 111(5):478-490. PubMed ID: 32955830
[TBL] [Abstract][Full Text] [Related]
25. Bispecific antibodies in acute lymphoblastic leukemia therapy.
Chitadze G; Laqua A; Lettau M; Baldus CD; Brüggemann M
Expert Rev Hematol; 2020 Nov; 13(11):1211-1233. PubMed ID: 33000968
[TBL] [Abstract][Full Text] [Related]
26. Dicentric translocation (9;12) presenting as refractory Philadelphia chromosome-positive acute B-cell lymphoblastic leukemia.
Bargetzi MJ; Mühlematter D; Tichelli A; Jotterand M; Wernli M
Cancer Genet Cytogenet; 1999 Aug; 113(1):90-2. PubMed ID: 10459354
[TBL] [Abstract][Full Text] [Related]
27. [Research Advances in the Treatment of B-Cell Acute Lymphoblastic Leukemia Based on Surface Antigen Expression --Review].
Su Y; Yin QS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):648-652. PubMed ID: 33812446
[TBL] [Abstract][Full Text] [Related]
28. Rare
Miyamoto S; Urayama KY; Arakawa Y; Koh K; Yuza Y; Hasegawa D; Taneyama Y; Noguchi Y; Yanagimachi M; Inukai T; Ota S; Takahashi H; Keino D; Toyama D; Takita J; Tomizawa D; Morio T; Koike K; Moriwaki K; Sato Y; Fujimura J; Morita D; Sekinaka Y; Nakamura K; Sakashita K; Goto H; Manabe A; Takagi M
Pediatr Hematol Oncol; 2024; 41(1):81-87. PubMed ID: 37129918
[TBL] [Abstract][Full Text] [Related]
29. ETV6/CBFA2 fusions in childhood B-cell precursor acute lymphoblastic leukemia with myeloid markers.
Rafi SK; El Gebaly H; Qumsiyeh MB
Diagn Mol Pathol; 2000 Dec; 9(4):184-9. PubMed ID: 11129441
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
31. Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
Tomuleasa C; Fuji S; Berce C; Onaciu A; Chira S; Petrushev B; Micu WT; Moisoiu V; Osan C; Constantinescu C; Pasca S; Jurj A; Pop L; Berindan-Neagoe I; Dima D; Kitano S
Front Immunol; 2018; 9():239. PubMed ID: 29515572
[TBL] [Abstract][Full Text] [Related]
32. [Applications of fluorescence in situ hybridization (FISH) in acute lymphoblastic leukemia].
Buades JM; Vizcarra Rabadán E; Sánchez Izquierdo D; Martínez-Climent JA
Sangre (Barc); 1999 Aug; 44(4):273-81. PubMed ID: 10589279
[No Abstract] [Full Text] [Related]
33. Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.
Eldfors S; Kuusanmäki H; Kontro M; Majumder MM; Parsons A; Edgren H; Pemovska T; Kallioniemi O; Wennerberg K; Gökbuget N; Burmeister T; Porkka K; Heckman CA
Leukemia; 2017 Jan; 31(1):51-57. PubMed ID: 27461063
[TBL] [Abstract][Full Text] [Related]
34. Pseudoprogression of extramedullary disease in relapsed acute lymphoblastic leukemia after CAR T-cell therapy.
Huang J; Rong L; Wang E; Fang Y
Immunotherapy; 2021 Jan; 13(1):5-10. PubMed ID: 33045890
[No Abstract] [Full Text] [Related]
35.
Li MJ; Yu CH; Chou SW; Su YH; Liao KW; Chang HH; Yang YL
JCO Precis Oncol; 2022 Aug; 6():e2200236. PubMed ID: 36001860
[No Abstract] [Full Text] [Related]
36. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy.
Watanabe A; Inukai T; Kagami K; Abe M; Takagi M; Fukushima T; Fukushima H; Nanmoku T; Terui K; Ito T; Toki T; Ito E; Fujimura J; Goto H; Endo M; Look T; Kamps M; Minegishi M; Takita J; Inaba T; Takahashi H; Ohara A; Harama D; Shinohara T; Somazu S; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2019 Sep; 8(11):5274-5288. PubMed ID: 31305009
[TBL] [Abstract][Full Text] [Related]
37. [Three cases of hematologic malignancies with jumping translocation].
Arioka H; Shikano T; Kobayashi R; Naito H; Ishikawa Y
Rinsho Ketsueki; 1994 Feb; 35(2):165-70. PubMed ID: 8139115
[TBL] [Abstract][Full Text] [Related]
38. [Chimeric antigen receptors T cells in treatment of a relapsed pediatric acute lymphoblastic leukemia, relapse after allogenetic hematopoietic stem cell transplantation: case report and review of literature review].
Zuo Y; Wang J; Lu A; Jia Y; Wu J; Dong L; Chang L; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):115-8. PubMed ID: 27014980
[TBL] [Abstract][Full Text] [Related]
39. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
[TBL] [Abstract][Full Text] [Related]
40. Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.
Mankuzhy NP; Walling E; Anderson B; Mody R
J Pediatr Hematol Oncol; 2019 Nov; 41(8):653-656. PubMed ID: 30028819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
